Priority Date: 20.07.12 (FR 20120057082)

IMIDAZOPYRIDINE DERIVATIVE USED IN THE TREATMENT OF DIABETES

  • Application ID: EP13744752
  • Status: PATENT GRANTED

Attorneys

operating since 1930
Headquarter in Paris, Düsseldorf and 6 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
no operation time available
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.07.2012 - Priority Date (FR 20120057082)
  • 23.01.2014 - Publication A1 (WO2014013182)
  • 27.05.2015 - Publication A1 (EP2875026)
  • 21.09.2016 - Publication B1 (EP2875026)

IPC Classification